Standard

Harvard

APA

Vancouver

Author

BibTeX

@article{cd004c097c404afba5ddd5eef5c2166d,
title = "Current role of modern chromatography with mass spectrometry and nuclear magnetic resonance spectroscopy in the investigation of biomarkers of endometriosis",
abstract = "Endometriosis has a wide range of clinical manifestations, and the disease course is unpredictable, making the diagnosis a challenging task. Despite significant advances in the pathophysiology of endometriosis and various proposed theories, the exact etiology is not fully understood and is still unknown. The most commonly used biomarker of endometriosis is CA-125, however, it is nonspecific and is applied for cancers diagnosis. Therefore, the development of reliable noninvasive diagnostic tests for the early diagnosis of endometriosis remains one of the top priorities. Omics technologies are very promising approaches for constructing diagnostic models and biomarker discovery. Their use can greatly facilitate the study of such a complex disease as endometriosis. Nowadays, powerful analytical platforms commonly used in omics, such as gas and liquid chromatography with mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy, have proven to be a promising tools for biomarker discovery. The aim of this review is to summarize the various features of the analytical approaches, practical challenges and features of gas and liquid chromatography with MS and NMR spectroscopy (including sample processing protocols, technological advancements, and methodology) used for profiling of metabolites, lipids, peptides and proteins in physiological fluids and tissues from patients with endometriosis. In addition, this report devotes special attention to the issue of how comprehensive analyses of these profiles can effectively contribute to the study of endometriosis. The search query included reports published between 2012 and 2022 years in PubMed, Web-of-Science, SCOPUS, Science Direct.",
keywords = "Endometriosis; NMR spectroscopy; biomarkers; chromatography mass spectrometry; omics technologies",
author = "Карцова, {Людмила Алексеевна} and Бессонова, {Елена Андреевна} and Деев, {Владислав Александрович} and Колобова, {Екатерина Алексеевна}",
year = "2023",
month = jan,
day = "10",
doi = "10.1080/10408347.2022.2156770",
language = "English",
journal = "Critical Reviews in Analytical Chemistry",
issn = "1040-8347",
publisher = "Taylor & Francis",

}

RIS

TY - JOUR

T1 - Current role of modern chromatography with mass spectrometry and nuclear magnetic resonance spectroscopy in the investigation of biomarkers of endometriosis

AU - Карцова, Людмила Алексеевна

AU - Бессонова, Елена Андреевна

AU - Деев, Владислав Александрович

AU - Колобова, Екатерина Алексеевна

PY - 2023/1/10

Y1 - 2023/1/10

N2 - Endometriosis has a wide range of clinical manifestations, and the disease course is unpredictable, making the diagnosis a challenging task. Despite significant advances in the pathophysiology of endometriosis and various proposed theories, the exact etiology is not fully understood and is still unknown. The most commonly used biomarker of endometriosis is CA-125, however, it is nonspecific and is applied for cancers diagnosis. Therefore, the development of reliable noninvasive diagnostic tests for the early diagnosis of endometriosis remains one of the top priorities. Omics technologies are very promising approaches for constructing diagnostic models and biomarker discovery. Their use can greatly facilitate the study of such a complex disease as endometriosis. Nowadays, powerful analytical platforms commonly used in omics, such as gas and liquid chromatography with mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy, have proven to be a promising tools for biomarker discovery. The aim of this review is to summarize the various features of the analytical approaches, practical challenges and features of gas and liquid chromatography with MS and NMR spectroscopy (including sample processing protocols, technological advancements, and methodology) used for profiling of metabolites, lipids, peptides and proteins in physiological fluids and tissues from patients with endometriosis. In addition, this report devotes special attention to the issue of how comprehensive analyses of these profiles can effectively contribute to the study of endometriosis. The search query included reports published between 2012 and 2022 years in PubMed, Web-of-Science, SCOPUS, Science Direct.

AB - Endometriosis has a wide range of clinical manifestations, and the disease course is unpredictable, making the diagnosis a challenging task. Despite significant advances in the pathophysiology of endometriosis and various proposed theories, the exact etiology is not fully understood and is still unknown. The most commonly used biomarker of endometriosis is CA-125, however, it is nonspecific and is applied for cancers diagnosis. Therefore, the development of reliable noninvasive diagnostic tests for the early diagnosis of endometriosis remains one of the top priorities. Omics technologies are very promising approaches for constructing diagnostic models and biomarker discovery. Their use can greatly facilitate the study of such a complex disease as endometriosis. Nowadays, powerful analytical platforms commonly used in omics, such as gas and liquid chromatography with mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy, have proven to be a promising tools for biomarker discovery. The aim of this review is to summarize the various features of the analytical approaches, practical challenges and features of gas and liquid chromatography with MS and NMR spectroscopy (including sample processing protocols, technological advancements, and methodology) used for profiling of metabolites, lipids, peptides and proteins in physiological fluids and tissues from patients with endometriosis. In addition, this report devotes special attention to the issue of how comprehensive analyses of these profiles can effectively contribute to the study of endometriosis. The search query included reports published between 2012 and 2022 years in PubMed, Web-of-Science, SCOPUS, Science Direct.

KW - Endometriosis; NMR spectroscopy; biomarkers; chromatography mass spectrometry; omics technologies

UR - https://www.mendeley.com/catalogue/619fa7a5-ec9e-3dc6-8276-bee02c1ace57/

U2 - 10.1080/10408347.2022.2156770

DO - 10.1080/10408347.2022.2156770

M3 - Article

JO - Critical Reviews in Analytical Chemistry

JF - Critical Reviews in Analytical Chemistry

SN - 1040-8347

ER -

ID: 113806124